Top Markets
#1 Akedo Akedo +70.44%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.33%
#4 Cross Cross +45.97%
#5 Velvet Velvet +34.78%
#6 Black Phoenix Black Phoenix +34.22%
#7 OVERTAKE OVERTAKE +21.57%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#9 Movement Movement +13.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.14%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
Rangering i aksjer #38980
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Aksjekurs
$8.69
Markedsverdi
$707.69K
Endring (1 dag)
3.82%
Endring (1 år)
-94.05%
Land
US
Handel Niki BioSolutions, Inc. (NIKI)

Kategori

Healthcare
P/S-forhold for Niki BioSolutions, Inc. (NIKI)
P/S-forhold per 2026 TTM: 0
Ifølge Niki BioSolutions, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Niki BioSolutions, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE